101283-34-5

Basic information

• Product Name: Acetamide, N-(4-acetylphenyl)-N-phenyl-
• CAS NO: 101283-34-5
• Molecular Formula: C16H15NO2
• Molecular Weight: 253.301
• Mol File: 101283-34-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Acetamide, N-(4-acetylphenyl)-N-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(4-acetylphenyl)-N-phenyl-(101283-34-5)
• EPA Substance Registry System: Acetamide, N-(4-acetylphenyl)-N-phenyl-(101283-34-5)

Safety Data

• Hazardous Substances Data: 101283-34-5(Hazardous Substances Data)

Upstream product

• 88-65-3 2-bromobenzoic-acid 
• 23600-83-1 1-(4-(phenylamino)phenyl)ethanone 
• 108-24-7 acetic anhydride 
• 23600-82-0 N-(4-acetylphenyl)anthranilic acid 
• 591-50-4 iodobenzene 
• 13329-40-3 4-Iodoacetophenone 
• 103-84-4 Acetanilid 

Relevant articles and documents

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R1 and R2 are notably independently hydrogen, alkyl or cycloalkyl or R1 and R2, taken together with the carbon atom which carries them, form a carbocycle with 3 to 7 members and Ω is —NR46R47 or —OR48, R46 and R47 are notably independently hydrogen, alkyl, cycloalkyl or —(CH2)k—COOR51, R51 is notably alkyl or haloalkyl and R48 is notably hydrogen or alkyl. These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R1 and R2 are notably independently hydrogen, alkyl or cycloalkyl and Ω is —NR46R47 or —OR48 R46 and R47 are notably independently hydrogen, alkyl, cycloalkyl or —(CH2)k—COOR51, R51 is notably alkyl or haloalkyl and R48 is notably hydrogen or alkyl. These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.